BIO
Bio-Rad Laboratories
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: BIO
- PE Ratio
The PE ratio for Bio-Rad Laboratories stock stands at 50.92 as of Jul 2, 2026. This takes into account the latest EPS of $5.83 and stock price of $296.86.
BIO PE ratio history
Over the last ten years, the average PE ratio of Bio-Rad Laboratories has been 67.32. The current 50.92 P/E ratio is 24% lower than the historical average. Looking back at the last ten years, BIO's PE ratio peaked in the Jun 2017 quarter at 514.34, with a price of $226.31 and an EPS of $0.44. The Sep 2021 quarter marked the lowest point at 3.34, with a price of $745.95 and an EPS of $223.61.
Bio-Rad Laboratories PE ratio by year
Maximum annual increase: 458.78% in 2016
Maximum annual decrease: -72.03% in 2017
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 10.87 | N/A | $302.99 | $27.87 |
| 2024 | N/A | N/A | $328.51 | -$65.36 |
| 2023 | N/A | N/A | $322.89 | -$21.82 |
| 2022 | N/A | N/A | $420.49 | -$121.79 |
| 2021 | 5.3 | 16.48% | $755.57 | $142.61 |
| 2020 | 4.55 | -27.55% | $582.94 | $128.13 |
| 2019 | 6.28 | -66.88% | $370.03 | $58.93 |
| 2018 | 18.96 | -67.27% | $232.22 | $12.25 |
| 2017 | 57.93 | -72.03% | $238.67 | $4.12 |
| 2016 | 207.14 | 458.78% | $182.28 | $0.88 |
| 2015 | 37.07 | -5.29% | $138.66 | $3.74 |
| 2014 | 39.14 | -13.86% | $120.56 | $3.08 |
| 2013 | 45.44 | 153.01% | $123.61 | $2.72 |
| 2012 | 17.96 | 19.49% | $105.05 | $5.85 |
| 2011 | 15.03 | -3.03% | $96.04 | $6.39 |
Bio-Rad Laboratories PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 47.81 | 339.83% | $278.75 | $5.83 |
| Dec 2025 | 10.87 | N/A | $302.99 | $27.87 |
| Sep 2025 | N/A | N/A | $280.39 | -$24.21 |
| Jun 2025 | 20.35 | N/A | $241.32 | $11.86 |
| Mar 2025 | N/A | N/A | $243.56 | -$76.07 |
| Dec 2024 | N/A | N/A | $328.51 | -$65.36 |
| Sep 2024 | N/A | N/A | $334.58 | -$27.62 |
| Jun 2024 | N/A | N/A | $273.11 | -$47.34 |
| Mar 2024 | N/A | N/A | $345.87 | -$10.67 |
| Dec 2023 | N/A | N/A | $322.89 | -$21.82 |
| Sep 2023 | N/A | N/A | $358.45 | -$5.99 |
| Jun 2023 | N/A | N/A | $379.12 | -$15.12 |
| Mar 2023 | N/A | N/A | $479.02 | -$6.58 |
| Dec 2022 | N/A | N/A | $420.49 | -$121.79 |
| Sep 2022 | N/A | N/A | $417.14 | -$201.71 |
BIO Price vs fair value
BIO average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
Currently, BIO's PE ratio is higher than its 5-year average, but it is lower than its 10-year average.
PE comparison
With a price to earnings (P/E) of 50.92, BIO ranks higher than the Healthcare sector, the industry and its peers average. In comparison with the Healthcare sector average of 26.04, Bio-Rad Laboratories's price to earnings (P/E) is 96% higher.
BIO PE vs peers
BIO's PE ratio stands higher than its peer stocks JNJ and GE. Bio-Rad Laboratories's current PE ratio of 50.92 is higher than the average of its peers, which is 34.89.
| Stock name | PE ratio | Market cap |
|---|---|---|
| A Agilent Technologies Inc | 26.14 | $36.91B |
| TMO Thermo Fisher Scientific Inc | 28.73 | $194.52B |
| JNJ Johnson & Johnson | 30.13 | $633.19B |
| DHR Danaher Corp | 38.14 | $140.09B |
| BDX Becton Dickinson & Co | 40.02 | $43.56B |
| GE General Electric Co | 46.15 | $393.88B |
| BIO Bio-Rad Laboratories Inc | 50.92 | $7.94B |
| HBIO Harvard Bioscience Inc | N/A | $27.74M |
Frequently asked questions
What is Bio-Rad Laboratories's PE ratio?
The price to earnings ratio for BIO stock is 50.92 as of Jul 2, 2026.
What is the 5-year average PE ratio for Bio-Rad Laboratories (BIO)?
As an average over the last 5 years, BIO stock has a PE ratio of 17.53.
What is the highest PE ratio for BIO?
The highest quarterly PE ratio in the last ten years has been 514.34 and it was in the Jun 2017 quarter.
How does the current PE ratio for BIO compare to its historical average?
BIO's price to earnings ratio is currently 24% below its 10-year historical average.
How is BIO's PE ratio calculated (Bio-Rad Laboratories PE ratio formula)?
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Jul 2, 2026), Bio-Rad Laboratories's share price is $296.86. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $5.83. Therefore, Bio-Rad Laboratories's PE ratio for today is 50.92. PE RATIO(50.92) = STOCK PRICE($296.86) / TTM EPS($5.83)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.